NEJM Interviews
by NEJM Group
Is this your podcast?On the show
From 10 epsHost
Recent guests
Recent episodes
NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients.
Oct 14, 2026
13m 49s
NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity.
Oct 7, 2026
5m 35s
NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds.
Sep 30, 2026
8m 50s
NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.
Sep 23, 2026
13m 16s
NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.
Sep 16, 2026
9m 23s
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
No chart positions, follower counts or reviews yet. We will not guess.
Built from
By chart position
- 🇮🇩ID · Medicine#27N/A
- 🇧🇷Brazil · Medicine#127N/A
- 🇨🇴CO · Medicine#28N/A
- 🇯🇵Japan · Medicine#78N/A
- 🇲🇽Mexico · Medicine#124N/A
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 ~2x weekly·952 episodes·Last published 4d ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 10/14/26 |  NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients. | Lena Makaroun is an assistant professor of medicine at the University of Pittsburgh School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.K. Makaroun, T.W. Farrell, and M.E. Betz. Firearm-Related Discussions as an Age-Friendly Intervention. N Engl J Med 2026;395:1461-1463. | 13m 49s | ||||||
| 10/7/26 | NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity. | Sarah Schmitz is an obesity medicine specialist at Weill Cornell Medicine and an assistant attending physician at New York–Presbyterian Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Schmitz. Beyond Percentage of Weight Lost — Protecting Participants in Obesity Trials. N Engl J Med 2026;395:1355-1357. | 5m 35s | ||||||
| 9/30/26 | NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds. | Benjamin Scher is a lecturer and postdoctoral research associate in the Global Health Program at Princeton University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.D. Scher and H.H. Howard. Opioid-Settlement Funds — Lessons from Tobacco. N Engl J Med 2026;395:1249-1251. | 8m 50s | ||||||
| 9/23/26 | NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends. | Christopher Forrest is a professor of pediatrics and the director of the Applied Clinical Research Center at Children’s Hospital of Philadelphia. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.B. Forrest and N. Halfon. Declining Child Health in the United States — Addressing the Developmental Ecosystem. N Engl J Med 2026;395:1147-1149. | 13m 16s | ||||||
| 9/16/26 | NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. | Dhruv Khullar is an associate professor of population health sciences and of medicine at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D. Khullar. Artificial Intelligence and the Future of the Clinical Workforce. N Engl J Med 2026;395:1041-1043. | 9m 23s | ||||||
| 9/9/26 | preventive servicesevidence-based recommendations+3 | Elizabeth Kaplan | Center for Health Law and Policy InnovationHarvard Law School+4 | — | preventive servicesevidence-based+5 | — | 11m 35s | ||
| 9/2/26 | telehealthmifepristone+3 | Elizabeth Tobin-Tyler | Brown University School of Public HealthWarren Alpert Medical School of Brown University+3 | — | telehealthmifepristone+4 | — | 11m 53s | ||
| 8/19/26 | medical marijuanaresearch impact+3 | Rebecca Haffajee | Yale School of Public HealthNEJM+1 | — | medical marijuanaresearch+3 | — | 13m 08s | ||
| 8/12/26 | pay-for-performancehealth care quality+3 | Eric Schneider | Harvard T.H. Chan School of Public HealthNEJM+2 | — | pay-for-performancehealth care quality+3 | — | 8m 55s | ||
| 8/5/26 | outbreak preparednessequitable partnerships+3 | Jean Nachega | Stellenbosch UniversityUniversity of Pittsburgh School of Public Health+2 | — | outbreak preparednesscommunity trust+3 | — | 11m 14s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 7/29/26 | litigationhealth risks+3 | Jerry Avorn | Harvard Medical SchoolBrigham and Women’s Hospital+2 | — | litigationhealth risks+3 | — | 14m 12s | ||
| 7/22/26 | vaccine evaluationpublic health+3 | Arnold Monto | University of Michigan School of Public HealthNEJM+2 | — | vaccine protectionepidemiology+3 | — | 8m 40s | ||
| 7/15/26 | medication managementautism care+3 | Yaara Zisman-Ilani | Temple UniversityN Engl J Med+1 | — | autismmedication management+3 | — | 8m 05s | ||
| 7/8/26 | long-term carenursing home capacity+3 | Mark Unruh | Weill Cornell Medical CollegeN Engl J Med | — | long-term servicesnursing-home capacity+3 | — | 5m 40s | ||
| 7/1/26 | physician leadershipAmerican society+3 | Justin Barr | Ochsner ClinicNEJM+1 | — | physician leadershipAmerican politics+3 | — | 11m 08s | ||
| 6/24/26 | NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. | Stacie Dusetzina is a professor of health policy and of cancer research at the Vanderbilt University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina. Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? N Engl J Med 2026;394:2385-2387. | 13m 06s | ||||||
| 6/17/26 | NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States. | Marcus Hughes is an assistant professor of psychiatry at the Yale School of Medicine and an attending psychiatrist at Yale New Haven Psychiatric Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Hughes. Psychedelic Therapies in the United States — Balancing State and Federal Oversight. N Engl J Med 2026;394:2281-2283. Y. Zisman-Ilani and R. Yehuda. Patient-Driven Care in Psychedelic Therapy. N Engl J Med 2026;394:2284-2286. | 9m 02s | ||||||
| 6/10/26 | NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress. | Edward Ryan is the director of global infectious diseases at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.T. Ryan, F. Qadri, and J.A. Lynch. Global Cholera-Control Efforts — Progress and Remaining Challenges. N Engl J Med 2026;394:2177-2180. | 12m 17s | ||||||
| 6/3/26 | NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable. | Loren Adler is a fellow and the associate director at the Center on Health Policy at the Brookings Institution. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Adler. Regulating Corporate Control in the U.S. Health Care System. N Engl J Med 2026;394:2073-2076. | 10m 14s | ||||||
| 5/27/26 | NEJM Interview: Deirdre Tobias on the 2025–2030 Dietary Guidelines for Americans, including areas of confusion and contradiction. | Deirdre Tobias is an associate professor in the Department of Nutrition at the Harvard T.H. Chan School of Public Health and Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.K. Tobias and F.B. Hu. The 2025–2030 Dietary Guidelines for Americans — Progress, Pitfalls, and the Path Forward. N Engl J Med 2026;394:1969-1971. | 14m 27s | ||||||
| 5/26/26 |  NEJM Outbreaks Updates — Andes Hantavirus | Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Angela Hewlett is Director of the Nebraska Biocontainment Unit. Steven Kornfeld is a physician who was a passenger on the MV Hondius. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. NEJM Outbreaks Update — Andes Hantavirus. N Engl J Med. DOI: 10.1056/NEJMe2505379. | 27m 53s | ||||||
| 5/13/26 | NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from expressing undue confidence in their knowledge. | Raja-Elie Abdulnour is the Chief Clinical Innovation Officer at NEJM Group and an associate physician in the Pulmonary and Critical Care Medicine Division at Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Sikora, L.A. Celi, and R.-E.E. Abdulnour. Can AI Say “I Don’t Know”? N Engl J Med 2026;394:1873-1875. | 12m 57s | ||||||
| 5/6/26 | NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medical education and trainee development. | Jatin Vyas is a professor of medicine and associate dean for academic innovation at the Columbia University Vagelos College of Physicians and Surgeons. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Vyas. From Mission to Margin in Academic Medicine — The Impact of Corporate Medicine on Medical Training. N Engl J Med 2026;394:1769-1772. | 8m 53s | ||||||
| 4/29/26 | NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders. | Amanda Banks is a consultant and a physician at the Corporal Michael J. Crescenz VA Medical Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Banks. GLP-1 Receptor Agonists and Eating Disorders — Cause for Concern. N Engl J Med 2026;394:1665-1667. | 9m 30s | ||||||
| 4/22/26 | NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions. | Sara Gerke is an associate professor of law and at the European Union Center at the University of Illinois Urbana-Champaign. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Gerke, R.B. Parikh, and I.G. Cohen. Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care. N Engl J Med 2026;394:1561-1563. | 9m 10s | ||||||
Showing 25 of 952
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for NEJM Interviews
Peaked at #27 in ID, currently #27 in ID.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| ID | — | #27 | #27 | — |
| CO | — | #28 | #28 | — |
| Japan | — | #78 | #78 | — |
| South Korea | — | #117 | #117 | — |
| Mexico | — | #124 | #124 | — |
| Brazil | — | #127 | #127 | — |
| HK | — | #143 | #143 | — |
| RO | — | #161 | #161 | — |
| Sweden | — | #165 | #165 | — |
| PL | — | #168 | #168 | — |
| SG | — | #174 | #174 | — |
| TW | — | #181 | #181 | — |
| IL | — | #182 | #182 | — |
| Finland | — | #189 | #189 | — |
| SA | — | #199 | #199 | — |
Chart Positions
15 placements across 15 markets.
Chart Positions
15 placements across 15 markets.